Neomed Innovation V L.p. - Net Worth and Insider Trading
Neomed Innovation V L.p. Net Worth
The estimated net worth of Neomed Innovation V L.p. is at least $299,335 dollars as of 2024-11-13. Neomed Innovation V L.p. is the 10% Owner of X4 Pharmaceuticals Inc and owns about 867,639 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $299,335. Details can be seen in Neomed Innovation V L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neomed Innovation V L.p. has not made any transactions after 2017-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neomed Innovation V L.p.
Neomed Innovation V L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neomed Innovation V L.p. owns 2 companies in total, including Axonics Inc (AXNX) , and X4 Pharmaceuticals Inc (XFOR) .
Click here to see the complete history of Neomed Innovation V L.p.’s form 4 insider trades.
Insider Ownership Summary of Neomed Innovation V L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AXNX | Axonics Inc | 2018-10-30 | 10 percent owner |
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 10 percent owner |
Neomed Innovation V L.p. Latest Holdings Summary
Neomed Innovation V L.p. currently owns a total of 1 stock. Neomed Innovation V L.p. owns 867,639 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $299,335.
Latest Holdings of Neomed Innovation V L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 867,639 | 0.35 | 299,335 |
Holding Weightings of Neomed Innovation V L.p.
Neomed Innovation V L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Neomed Innovation V L.p. has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 300,000 shares on November 20, 2017, which cost Neomed Innovation V L.p. around $3 Million.
Insider Trading History of Neomed Innovation V L.p.
- 1
Neomed Innovation V L.p. Trading Performance
GuruFocus tracks the stock performance after each of Neomed Innovation V L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neomed Innovation V L.p. is 0.28%. GuruFocus also compares Neomed Innovation V L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Neomed Innovation V L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Neomed Innovation V L.p.'s insider trading performs compared to the benchmark.
Performance of Neomed Innovation V L.p.
Neomed Innovation V L.p. Ownership Network
Ownership Network List of Neomed Innovation V L.p.
Ownership Network Relation of Neomed Innovation V L.p.
Neomed Innovation V L.p. Owned Company Details
What does Axonics Inc do?
Who are the key executives at Axonics Inc?
Neomed Innovation V L.p. is the 10 percent owner of Axonics Inc. Other key executives at Axonics Inc include Chief Financial Officer Kari Leigh Keese , Chief Medical Officer Karen Noblett , and director & Chief Executive Officer Raymond W Cohen .
Axonics Inc (AXNX) Insider Trades Summary
Over the past 18 months, Neomed Innovation V L.p. made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 15,674 shares made by Danny L. Dearen .
In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 141,355 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 141,355 shares.
Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axonics Inc Insider Transactions
Neomed Innovation V L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Neomed Innovation V L.p.. You might contact Neomed Innovation V L.p. via mailing address: 13, Castle Street, St. Helier Y9 Je4 5ut.